Publication details

Risperidon v léčbě hyperkinetické poruchy / ADHD u dětí

Title in English Risperidone in the treatment of hyperkinetic disorder / ADHD in children
Authors

DRTÍLKOVÁ Ivana

Year of publication 2013
Type Article in Periodical
Magazine / Source Česká a slovenská psychiatrie
MU Faculty or unit

Faculty of Medicine

Citation
Field Psychiatry, sexuology
Keywords ADHD; Children; Methylphenidate; Risperidone
Description There has been a significant increase in the use of psychiatric medication in children over the last few decades, specifically dopamine agonists (stimulants) and dopamine antagonists (antipsychot-ics) for attention deficit hyperactivity disorder (ADHD). Risperidone is not registered for the treatment of ADHD, it is approved for aggressive behaviour in children. Conduct disorder co-exist with ADHD approximately in 35% of children. Where aggression is severe, pervasive and persistent in the child or adolescent with ADHD, it may be justifiable to add in an atypical neuroleptic e.g. risperidone to the stimulant, or monotherapy with risperidone.

You are running an old browser version. We recommend updating your browser to its latest version.

More info